| 1821 |
|
Tumor-reactive, SSX-2-specific CD8^+ T Cells Are Selectively Expanded during Immune Responses to Antigen-expressing Tumors in Melanoma Patients/
|
Ayyoub, M
|
Williams and Wilkins
|
2003
|
|
|
|
| 1822 |
|
Tumor-specific Immunological Recognition of Frameshift-mutated Peptides in Colon Cancer with Microsatellite Instability/
|
Ishikawa, T
|
Williams and Wilkins
|
2003
|
|
|
|
| 1823 |
|
Tumor Suppression by a Rationally Designed Reversible Inhibitor of Methionine Aminopeptidase-2/
|
Wang, J
|
Williams and Wilkins
|
2003
|
|
|
|
| 1824 |
|
Tumor Suppression by the Prohibitin Gene 3'Untranslated Region RNA in Human Breast Cancer/
|
Manjeshwar, S
|
Williams and Wilkins
|
2003
|
|
|
|
| 1825 |
|
Typing the Histogenetic Origin of the Tumor Cells of Lymphocyte-rich Classical Hodgkin's Lymphoma in Relation to Tumor Cells of Classical and Lymphocyte-predominance Hodgkin's Lymphoma/
|
Brauninger, A
|
Williams and Wilkins
|
2003
|
|
|
|
| 1826 |
|
Up-Regulation of Hypoxia-inducible Factor 2alpha in Renal Cell Carcinoma Associated with Loss of Tsc-2 Tumor Suppressor Gene/
|
Liu, M. Y
|
Williams and Wilkins
|
2003
|
|
|
|
| 1827 |
|
Ursodeoxycholic Acid Inhibits Ras Mutations, Wild-type Ras Activation, and Cyclooxygenase-2 Expression in Colon Cancer/
|
Khare, S
|
Williams and Wilkins
|
2003
|
|
|
|
| 1828 |
|
Ursolic Acid Inhibits Nuclear Factor-kappaB Activation Induced by Carcinogenic Agents through Suppression of IkappaBalpha Kinase and p65 Phosphorylation: Correlation with Down-Regulation of Cyclooxygenase 2, Matrix Metalloproteinase 9, and Cyclin D1/
|
Shishodia, S
|
Williams and Wilkins
|
2003
|
|
|
|
| 1829 |
|
Use of a Vaccine Strain of Measles Virus Genetically Engineered to Produce Carcinoembryonic Antigen as a Novel Therapeutic Agent against Glioblastoma Multiforme/
|
Phuong, L. K
|
Williams and Wilkins
|
2003
|
|
|
|
| 1830 |
|
Use of Cycloxygenase-2 Inhibition to Enhance the Efficacy of Immunotherapy/
|
DeLong, P
|
Williams and Wilkins
|
2003
|
|
|
|
| 1831 |
|
Use of RNA Interference to Target Cyclin E-overexpressing Hepatocellular Carcinoma/
|
Li, K
|
Williams and Wilkins
|
2003
|
|
|
|
| 1832 |
|
Vascular Damage and Anti-angiogenic Effects of Tumor Vessel-Targeted Liposomal Chemotherapy/
|
Pastorino, F
|
Williams and Wilkins
|
2003
|
|
|
|
| 1833 |
|
Vascular Endothelial Growth Factor Gene Expression in Colon Cancer Cells Exposed to Prostaglandin E~2 Is Mediated by Hypoxia-inducible Factor 1/
|
Fukuda, R
|
Williams and Wilkins
|
2003
|
|
|
|
| 1834 |
|
Vascular-targeting Activity of ZD6126, a Novel Tubulin-binding Agent/
|
Micheletti, G
|
Williams and Wilkins
|
2003
|
|
|
|
| 1835 |
|
"Vasocrine" Formation of Tumor Cell-lined Vascular Spaces: Implications for Rational Design of Antiangiogenic Therapies/
|
Rybak, S. M
|
Williams and Wilkins
|
2003
|
|
|
|
| 1836 |
|
Virology - Detection of JC Virus DNA Sequences andd Expression of the Viral Regulatory Protein T-Antigen in Tumors of the Central Nervous System./
|
Valle, Luis Del
|
Williams and Wilkins
|
2001
|
|
|
|
| 1837 |
|
Werner Protein Stimulates Topoisomerase I DNA Relaxation Activity/
|
Laine, J.-P
|
Williams and Wilkins
|
2003
|
|
|
|
| 1838 |
|
Widespread Bimodal Intrachromosomal Genomic Instability in Sporadic Breast Cancers Associated with 13q Allelic Imbalance/
|
Przybytkowski, E
|
Williams and Wilkins
|
2003
|
|
|
|
| 1839 |
|
Wild-Type Breast Cancer Resistance Protein (BCRP/ABCG2) is a Methotrexate Polyglutamate Transporter/
|
Volk, E. L
|
Williams and Wilkins
|
2003
|
|
|
|
| 1840 |
|
Wnt Pathway Activation in Mesothelioma: Evidence of Dishevelled Overexpression and Transcriptional Activity of beta-Catenin/
|
Uematsu, K
|
Williams and Wilkins
|
2003
|
|
|
|